DeepLife is thrilled to announce a $10 million Series A round to propel our AI-powered Digital Twins of Cells platform!

✨Today, we’re excited to announce that DeepLife has successfully raised $10M in our Series A funding round! This marks a pivotal step in our mission to redefine the boundaries of drug discovery using generative AI and cutting-edge biotechnology.

💡 At DeepLife, our mission is to redefine how we discover and develop novel therapies. By creating “Digital Twins of Cells,” we empower pharma to explore new uses for over 8,000 existing drugs, transforming possibilities for patients worldwide.

🧬 Our platform has already begun unlocking possibilities that once seemed unattainable: after delivering breakthrough results in collaboration with Inserm earlier this year, we’re now commercializing our first solutions and forging strategic partnerships to uncover treatments for diseases long considered untreatable.

A heartfelt thank you to our lead investors YZR Capital, Turenne Groupe, alongside with Beiersdorf, and Groupe Prunay, for believing in our vision and supporting us on this journey. We’re deeply grateful to work with such forward-thinking partners who share our vision for the future of drug discovery.

We also owe a special thank you to our earliest investors and incredible community of Business Angels who have believed in us from the very beginning. Your unwavering and renewed support laid the foundation for everything we’ve achieved so far and continues to inspire us every day.

Here’s what this milestone enables:
🚀 Scaling Our Vision: Expanding our platform’s capabilities and validating applications in hashtagautoimmune and hashtagneurodegenerative diseases.
🌍 Global Expansion: Strengthening our presence in the US, the epicenter of drug discovery innovation.
🤝 Collaborating with Visionaries: Partnering with world-class researchers and industry leaders to accelerate therapeutic development.

This achievement is more than a funding round, it’s a testament to the incredible DeepLife team, whose talent, passion, and perseverance are transforming the future of drug discovery.

📢 We’re growing! Stay tuned for new opportunities to join our mission to make undruggable diseases a thing of the past.

We’re also thrilled to have our story featured on Sifted, where you can read more about this exciting chapter and our vision for the future of healthcare. Check it out here:
https://lnkd.in/edru7bCW

💡 Let’s build a world where no disease is beyond reach.

Newsletter
France Biotech

Laissez-nous votre adresse e-mail pour recevoir toutes les actualités de l’innovation santé et les informations exclusives de France Biotech.